Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and Erythema

3-iodobenzylguanidine has been researched along with Erythema in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edwards, K; Monaghan, R; Shao, F; Xie, P; Zhuang, H1
Borgström, P; Dahllöf, G; Jacobsson, H; Kogner, P; Lundell, G1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and Erythema

ArticleYear
Elevated MIBG Activity at the Site of Erythema of Unknown Etiology.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:3

    Topics: 3-Iodobenzylguanidine; Child; Erythema; Humans; Male; Neuroblastoma; Radiopharmaceuticals

2017
Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2001, Volume: 92, Issue:4

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Erythema; Fatal Outcome; Female; Humans; Infant; Mouth Mucosa; Neuroblastoma; Stomatitis

2001